Cargando…
Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies
The identification of factors that affect cannabidiol (CBD) systemic exposure may aid in optimizing treatment efficacy and safety in clinical practice. In this study, we aimed to correlate CBD plasma concentrations at a steady state to demographic, clinical, and pharmacological characteristics as we...
Autores principales: | Brstilo, Lucas, Reyes Valenzuela, Gabriela, Caraballo, Roberto, Pérez Montilla, Carlos, García Bournissen, Facundo, Cáceres Guido, Paulo, Schaiquevich, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459683/ https://www.ncbi.nlm.nih.gov/pubmed/37631333 http://dx.doi.org/10.3390/pharmaceutics15082120 |
Ejemplares similares
-
Add‐on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy
por: Kuchenbuch, Mathieu, et al.
Publicado: (2020) -
Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial
por: Scheffer, Ingrid E., et al.
Publicado: (2021) -
Inherited Developmental and Epileptic Encephalopathies
por: Bartolini, Emanuele
Publicado: (2021) -
Tubulinopathy Presenting as Developmental and Epileptic Encephalopathy
por: Hung, Kun-Long, et al.
Publicado: (2022) -
Dravet Syndrome: A Developmental and Epileptic
Encephalopathy
por: Lopez-Santiago, Luis, et al.
Publicado: (2019)